Therapeutic properties and and phytochemical profile of greater galangal

Announcing a new article publication for BIO Integration journal. Various secondary metabolite compounds from plants have been found in recent decades, one of which is Alpinia galanga L. (greater galangal). The world community has long recognized the Alpinia galanga L. plant as a raw material for traditional medicinal herbs that can help cure several diseases, such as ulcers, headaches, rheumatism, migraines, and diabetes mellitus.

Knowledge of the potential of medicinal ingredients from derivatives of metabolite compounds in Alpinia galanga L. has been continued by researchers through the science of herbal medicine. Researchers have found that all parts of this plant, including leaves, roots, stems, flowers, and rhizomes, have secondary metabolite compounds that have the potential to be developed for medicine. One part that contains an abundance of secondary metabolites, such as 1,8-cineole, α-fenchyl acetate, β-farnesene, β-bisabolene, α-bergamotene, β-pinene, 1′-acetoxychavicol acetate (ACE), galangin, phenylpropanoid, and β-sitosterol diglucoside (AG-7), is the rhizome. Research related to the bioactivity test of these secondary metabolite compounds is still being conducted by researchers to reveal other amazing potentials of Alpinia galanga L.

This review article provides information related to the ethnomedicinal profile, phytochemicals, and various medical potentials of Alpinia galanga L.

Source:
Journal reference:

Priyono, Q. A. P., et al. (2024) Ethnomedical Potentials, Phytochemicals, and Medicinal Profile of Alpinia galanga L.: A Comprehensive Review. BIO Integration. DOI: 10.15212/bioi-2024-0032.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Angiotensin receptor blockers found to lower epilepsy risk, new study reveals